A detailed history of Abrdn PLC transactions in Natera, Inc. stock. As of the latest transaction made, Abrdn PLC holds 34,276 shares of NTRA stock, worth $5.47 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
34,276
Previous 48,276 29.0%
Holding current value
$5.47 Million
Previous $5.23 Million 16.66%
% of portfolio
0.01%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

SELL
$97.75 - $129.67 $1.37 Million - $1.82 Million
-14,000 Reduced 29.0%
34,276 $4.36 Million
Q2 2024

Aug 09, 2024

SELL
$85.28 - $112.6 $3.16 Million - $4.18 Million
-37,110 Reduced 43.46%
48,276 $5.23 Million
Q1 2024

May 08, 2024

BUY
$59.21 - $92.9 $2.02 Million - $3.17 Million
34,078 Added 66.42%
85,386 $7.81 Million
Q4 2023

Jan 31, 2024

BUY
$37.55 - $62.64 $1.93 Million - $3.21 Million
51,308 New
51,308 $3.21 Million

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $15.5B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Abrdn PLC Portfolio

Follow Abrdn PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Abrdn PLC, based on Form 13F filings with the SEC.

News

Stay updated on Abrdn PLC with notifications on news.